Pharmaceutical drug

Results: 29669



#Item
21Food and Drug Administration, HHS  § 50.3 PART 50—PROTECTION OF HUMAN SUBJECTS

Food and Drug Administration, HHS § 50.3 PART 50—PROTECTION OF HUMAN SUBJECTS

Add to Reading List

Source URL: publicfiles.jaeb.org

Language: English - Date: 2014-01-30 11:37:23
22PRESS RELEASE  Oncodesign Biotechnology and Bristol-Myers Squibb enter into Strategic Drug Discovery Collaboration  Collaboration is based on Oncodesign’s Nanocyclix® technology

PRESS RELEASE Oncodesign Biotechnology and Bristol-Myers Squibb enter into Strategic Drug Discovery Collaboration  Collaboration is based on Oncodesign’s Nanocyclix® technology

Add to Reading List

Source URL: www.oncodesign.com

Language: English - Date: 2016-01-04 13:50:16
23Quasi Drug Rules in Japan December 2011 Quasi-drugs are a unique product classification in Japan. A quasi-drug is defined in Japan as products that have minimal to moderate pharmacologic activity but are restricted in us

Quasi Drug Rules in Japan December 2011 Quasi-drugs are a unique product classification in Japan. A quasi-drug is defined in Japan as products that have minimal to moderate pharmacologic activity but are restricted in us

Add to Reading List

Source URL: www.jetro.go.jp

Language: English - Date: 2015-03-30 22:38:04
24NON-INSURED HEALTH BENEFITS First Nations and Inuit Health Branch DRUG BENEFIT LIST 2016

NON-INSURED HEALTH BENEFITS First Nations and Inuit Health Branch DRUG BENEFIT LIST 2016

Add to Reading List

Source URL: healthycanadians.gc.ca

Language: English - Date: 2016-07-21 10:25:17
25IMDRF Presentation: Japan Update - New measures to improve access to innovative MDs/IVDs

IMDRF Presentation: Japan Update - New measures to improve access to innovative MDs/IVDs

Add to Reading List

Source URL: www.imdrf.org

Language: English - Date: 2015-09-10 20:03:11
26February 2016 Rx Price Watch Report

February 2016 Rx Price Watch Report

Add to Reading List

Source URL: www.aarp.org

Language: English - Date: 2016-02-27 18:42:24
27arXiv:1510.02855v1 [cs.LG] 10 OctAtomNet: A Deep Convolutional Neural Network for Bioactivity Prediction in Structure-based Drug Discovery

arXiv:1510.02855v1 [cs.LG] 10 OctAtomNet: A Deep Convolutional Neural Network for Bioactivity Prediction in Structure-based Drug Discovery

Add to Reading List

Source URL: arxiv.org

Language: English - Date: 2015-10-12 20:36:12
2827 JANUARY 2016 BIOSIMILARS DEVELOPMENT - FROM PRE-CLINIC TO MARKET Several biological products, altogether worth over US$60 billion annual sales, are encountering patent expiry byThis opens up the opportunity for

27 JANUARY 2016 BIOSIMILARS DEVELOPMENT - FROM PRE-CLINIC TO MARKET Several biological products, altogether worth over US$60 billion annual sales, are encountering patent expiry byThis opens up the opportunity for

Add to Reading List

Source URL: www.ideas-itn.eu

Language: English - Date: 2016-02-01 06:18:00
29Use of Standards in FDA Regulatory Oversight of Next Generation Sequencing (NGS)-Based In Vitro Diagnostics (IVDs) Used for Diagnosing Germline Diseases - Draft Guidance for Stakeholders and Food and Drug Administration

Use of Standards in FDA Regulatory Oversight of Next Generation Sequencing (NGS)-Based In Vitro Diagnostics (IVDs) Used for Diagnosing Germline Diseases - Draft Guidance for Stakeholders and Food and Drug Administration

Add to Reading List

Source URL: www.fda.gov

Language: English
302016 Shareholder Resolution JOHNSON & JOHNSON Request: Proper Disposal of Pharmaceuticals WHEREAS: Lack of free, convenient programs for proper disposal of unneeded or expired consumer prescription

2016 Shareholder Resolution JOHNSON & JOHNSON Request: Proper Disposal of Pharmaceuticals WHEREAS: Lack of free, convenient programs for proper disposal of unneeded or expired consumer prescription

Add to Reading List

Source URL: www.asyousow.org

Language: English - Date: 2015-11-11 13:04:01